ID: ALA4777405

Max Phase: Preclinical

Molecular Formula: C14H14BrN3O

Molecular Weight: 320.19

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1nn(-c2ccccn2)c2c1C(=O)CC(C)C2Br

Standard InChI:  InChI=1S/C14H14BrN3O/c1-8-7-10(19)12-9(2)17-18(14(12)13(8)15)11-5-3-4-6-16-11/h3-6,8,13H,7H2,1-2H3

Standard InChI Key:  NNSABVCGYBNBQX-UHFFFAOYSA-N

Associated Targets(Human)

CDK2/Cyclin A2 2260 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CDK1/Cyclin A 118 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 1/cyclin B1 1887 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CDK2/Cyclin A1 171 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 2/cyclin E1 1877 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CDK2/Cyclin O 24 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CDK3/Cyclin E 905 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 4/cyclin D1 2340 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 5/CDK5 activator 1 3697 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CDK6/cyclin D1 322 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 7/ cyclin H 714 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 320.19Molecular Weight (Monoisotopic): 319.0320AlogP: 3.23#Rotatable Bonds: 1
Polar Surface Area: 47.78Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.41CX LogP: 2.47CX LogD: 2.47
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.76Np Likeness Score: -0.91

References

1. Lee JC,Hong KH,Becker A,Tash JS,Schönbrunn E,Georg GI.  (2021)  Tetrahydroindazole inhibitors of CDK2/cyclin complexes.,  214  [PMID:33550184] [10.1016/j.ejmech.2021.113232]
2. Lee JC,Hong KH,Becker A,Tash JS,Schönbrunn E,Georg GI.  (2021)  Tetrahydroindazole inhibitors of CDK2/cyclin complexes.,  214  [PMID:33550184] [10.1016/j.ejmech.2021.113232]

Source